GDRX GoodRx Holdings Inc

Price (delayed)

$2.85

Market cap

$965.22M

P/E Ratio

47.5

Dividend/share

N/A

EPS

$0.06

Enterprise value

$1.27B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 60

GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different ...

Highlights
The quick ratio has plunged by 88% YoY and by 73% from the previous quarter
The company's EPS fell by 33% QoQ and by 14% YoY

Key stats

What are the main financial stats of GDRX

GDRX stock price

How has the GoodRx Holdings stock price performed over time
Intraday
1.42%
1 week
-4.04%
1 month
14%
1 year
-28.93%
YTD
5.17%
QTD
45.41%

Financial performance

How have GoodRx Holdings's revenue and profit performed over time
Revenue
$787.89M
Gross profit
$723.5M
Operating income
$78.15M
Net income
$20.56M
Gross margin
91.8%
Net margin
2.6%
GoodRx Holdings's net income has decreased by 32% QoQ and by 28% YoY
The net margin is down by 32% from the previous quarter and by 28% YoY
The operating margin has decreased by 11% QoQ
The company's operating income fell by 11% QoQ

Price vs fundamentals

How does GDRX's price correlate with its fundamentals

Growth

What is GoodRx Holdings's growth rate over time

Valuation

What is GoodRx Holdings stock price valuation
P/E
47.5
P/B
1.57
P/S
1.23
EV/EBIT
14.57
EV/EBITDA
7.17
EV/Sales
1.61
The company's EPS fell by 33% QoQ and by 14% YoY
The price to earnings (P/E) is 10% higher than the last 4 quarters average of 42.7
GDRX's P/B is 71% below its 5-year quarterly average of 5.3 and 18% below its last 4 quarters average of 1.9
GoodRx Holdings's equity has decreased by 4.9% YoY
The price to sales (P/S) is 79% lower than the 5-year quarterly average of 5.9 and 19% lower than the last 4 quarters average of 1.5

Efficiency

How efficient is GoodRx Holdings business performance
GoodRx Holdings's ROA has decreased by 39% from the previous quarter and by 33% YoY
The company's return on equity fell by 31% QoQ and by 20% YoY
The company's return on invested capital fell by 13% QoQ and by 8% YoY
The company's return on sales fell by 10% QoQ and by 8% YoY

Dividends

What is GDRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GDRX.

Financial health

How did GoodRx Holdings financials performed over time
GoodRx Holdings's total assets is 44% more than its total liabilities
The total liabilities has soared by 118% YoY and by 78% QoQ
The quick ratio has plunged by 88% YoY and by 73% from the previous quarter
The debt is 13% less than the equity
GoodRx Holdings's equity has decreased by 4.9% YoY
GDRX's debt to equity is up by 4.8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.